Company · CIK 0001974640 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Apogee Therapeutics, Inc. · APGE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 DForm 4 → | Sep 3, 5:30 pm EDT | Fairmount Funds Management LLC +3Director | 443,187 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Mark C. McKennaDirector | 20,000 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | William A Jones Jr.Director | 34,824 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Jennifer A. FoxDirector | 34,824 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Jane HendersonChief Financial Officer | 158,371 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Michael Thomas HendersonChief Executive Officer, Director | 920,941 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Nimish P ShahDirector | 1,750,000 | $135.11 | $236,442,500 | 0 | — | |
| Sep 2, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Carl DambkowskiChief Medical Officer | 168,498 | $135.06 | $185,708 | 0 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 DForm 4 → | Sep 3, 5:30 pm EDT | Fairmount Funds Management LLC +3Director | 6,823,567 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Mark C. McKennaDirector | 182,488 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | William A Jones Jr.Director | 32,488 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Carl DambkowskiChief Medical Officer | 319,317 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Jennifer A. FoxDirector | 32,488 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Jane HendersonChief Financial Officer | 383,997 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Lisa BollingerDirector | 48,780 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Michael Thomas HendersonChief Executive Officer, Director | 997,064 | — | — | 0 | — | |
| Sep 3, 2026 DForm 4 → | Sep 3, 4:39 pm EDT | Nimish P ShahDirector | 7,189,420 | $135.11 | $911,090,100 | 0 | — |